The biological activity of human monoclonal IgG anti-D is reduced by beta-galactosidase treatment.Belinda M. Kumpel, G.A.W. Rook, Yan Wang et al.|PubMed|1995Cited by 71
The biological activity of human monoclonal IgG anti-D is reduced by β-galactosidase treatmentBelinda M. Kumpel, G.A.W. Rook, Yan Wang et al.|Human Antibodies|1995Cited by 68
Correlation of serological, quantitative and cell‐mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newbornAndrew G. Hadley, Iain D. C. Fraser, Belinda M. Kumpel et al.|British Journal of Haematology|1991Cited by 61
Functional interactions of red cells sensitized by IgG1 and IgG3 human monoclonal anti-D with enzyme-modified human monocytes and FcR-bearing cell linesBelinda M. Kumpel, Andrew G. Hadley|Molecular Immunology|1990Cited by 52
The chemiluminescent response of human monocytes to red cells sensitized with monoclonal anti-Rh(D) antibodiesAndrew G. Hadley, Anthony H. Merry, Belinda M. Kumpel|Clinical & Laboratory Haematology|1988Cited by 47